Kissei
id:
kissei-198-14209391
title:
Kissei
text:
Kissei Pharmaceutical is a pharmaceutical company based in Matsumoto, Nagano, Japan. Products discovered or developed by Kissei include: Difelikefalin
Fostamatinib
Linzagolix
Mitiglinide (Glufast)
Remogliflozin etabonate
Silodosin (Urief)
Tranilast (Rizaben) In March 2020, Kissei and CG Oncology, Inc. announced an exclusive license, development, and commercialization agreement for CG's oncolytic immunotherapy drug CG0070. The agreement covered Japan, South Korea, Taiwan, and other Asian countrie
brand slug:
wiki
category slug:
encyclopedia
description:
original url:
https://en.wikipedia.org/wiki/Kissei
date created:
date modified:
2024-02-24T14:53:18Z
main entity:
{"identifier":"Q11296797","url":"https://www.wikidata.org/entity/Q11296797"}
image:
fields total:
13
integrity:
13